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Background: Chronic kidney disease (CKD) is highly prevalent in Taiwan. More than two-thirds of end-stage renal
disease is associated with diabetes mellitus (DM) or hypertension (HTN). Therefore, the formulation of a special
preventative policy of CKD in these patients is essential. This study surveyed 14 traditional risk factors and identified
their effects on CKD in patients with HTN/DM and compared these with their effects in the general population.
Methods: This study included 5328 cases and 5135 controls in the CKD/HTN/DM outpatient and health centres of
10 hospitals from 2008 to 2010. Fourteen common effect factors were surveyed (four demographic, five disease and
five lifestyle), and their effects on CKD were tested. Significance tests were adjusted by the Bonferroni method.
Results of the stratified analyses in the variables were presented with significant heterogeneity between patients
with different comorbidities.
Results: Male, ageing, low income, hyperuricemia and lack of exercise habits were risk factors for CKD, and their
effects in people with different comorbidities were identical. Anaemia was a risk factor, and there was an additive
effect between anaemia and HTN on CKD. Patients with anaemia had a higher risk when associated with HTN
[odds ratio (OR) = 6.75, 95 % confidence limit (95 % CI) 4.76–9.68] but had a smaller effect in people without HTN
(OR 2.83, 95 % CI 2.16–3.67). The association between hyperlipidaemia-related factors and CKD was also moderated
by HTN. It was a significant risk factor in people without HTN (OR = 1.67, 95 % CI 1.38–2.01) but not in patients with
HTN (OR =1.03, 95 % CI 0.89–1.19). Hepatitis B, hepatitis C, betel nut chewing, smoking, alcohol intake and groundwater
use were not associated with CKD in multivariate analysis.
Conclusions: We considered that patients with HTN and anaemia were a high CKD risk population. Physicians with
anaemic patients in outpatient clinics need to recognise that patients who also have HTN might be latent CKD cases.
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Chronic kidney disease (CKD) is an important public
health issue because these patients have an increased risk
of end-stage renal disease (ESRD). Taiwan has a high
prevalence of CKD [1] and ESRD [2]. These patients are
at increased risk for cardiovascular events and progression
to kidney failure [3]. The benefits of screening at-risk
populations and estimating progression of CKD are well
established [4]. A previous study has shown that screening
people with hypertension (HTN), diabetes mellitus (DM)
or age >55 years is the most effective strategy to detect
patients with CKD [5]. Therefore, planning a specific
population screening/prevention strategy for people with
HTN or DM is a major public health challenge. To our
knowledge, there is no systematic evidence at present to
confirm that a screening/prevention strategy for the gen-
eral population would apply to high risk groups.
CKD is a complex disease that has complex aetiologies,
but the effects of these factors are mild. The traditional
factors that have an effect on CKD are primarily divided
into three parts: demographic characteristics (gender [6],
age [7], obesity [8] and social economic [9]), comorbidity
[hepatitis B (HB) [10], hepatitis C (HC) [11], hyperurice-
mia [7], anaemia [12] and hyperlipidaemia [7]] and
lifestyles (smoking status [13], alcohol intake [14], betel
nut chewing [15], exercise habits [16, 17] and groundwater
use [18]). Foregoing factors have been extensively investi-
gated and some studies have investigated their effects in
populations. However, these reported effects are inconsist-
ent in different populations. For example, obesity had a
significant effect in the general population [8] but not in
patients with DM [19]. This suggests that the effects of
obesity on CKD may be associated with DM. In addition,
several studies have investigated the interaction between
some of these factors and HTN/DM on CKD. Other
studies have reported an interaction between HTN and
smoking [20] and between DM and hyperuricemia [21]
on renal outcomes. As a result of these various reports,
we suspected that the effect of each factor on CKD may
be different in healthy populations and in patients with
DM/HTN.
Studies have shown evidence that the effects of some
factors on CKD may depend on the presence of DM or
HTN, which means that some risk factors may or may not
be important in patients with HTN/CKD. This informa-
tion may be important for clinical decision making for
CKD patients with HTN/CKD. However, to our know-
ledge, no study has systematically investigated the poten-
tial factors which may have a DM- or HTN-dependent
effect on CKD. Therefore, the aim of this study was to
investigate different targets for screening/prevention
strategies between healthy people and patients with HTN
or DM that may aid in planning most effective prevention
strategies for patients with DM and HTN.Methods
Population and definition
A multi-centre project in January 2008 to July 2010 was
conducted to survey the risk factors for CKD in Taiwan.
Fourteen hospitals equally participated in the program. Be-
fore starting the study, appropriate sample size estimation
was calculated using OpenEpi (http://www.openepi.com/
SampleSize/SSCC.htm). The settings used were: a two-
sided test with a power of (1 − β) = 0.95 at a significance
level of α = 0.05/14, the ratio of controls to cases = 1, the
hypothetical proportion of controls with exposure = 5 and
the least extreme odds ratio (OR) to be detected = 1.5.
Based on these settings, the study sample size required was
at least 9104 subjects.
To identify the specific risk factors in patients with
HTN/DM and to maintain the statistical power of this
study, a higher number of patients with HTN/DM were
required. Based on this, we also recruited participants
without CKD from HTN/DM outpatient and health cen-
tres from each hospital as the control group. The CKD
cases were recruited from nephrology and HTN/DM
outpatient clinics in each hospital and from health cen-
tres and were classified as the case group. Finally, a total
of 12,082 participants older than 18 years were recruited
consecutively in this project (Fig. 1).
The study included 11,552 (95.6 %) participants with
no missing DM and HTN status information. Exclusions
included 524 participants who had cancer and 565 from
four hospitals because of insufficient recruitment numbers
(<150 participants from three hospitals and one had only
75 healthy controls). Finally, a total of 10,463 (5218 male
and 5245 female) participants (median age 57.0 years)
from 10 different hospitals were included in the study.
CKD was defined as an estimated glomerular filtration
rate (eGFR) of <60 mL/min/1.73 m2 or with proteinuria.
The eGFR was calculated with the equation eGFR (mL/
min/1.73 m2) = 186 × Cr−1.154 × age−0.203 × 0.742 (if female)
[22]. A total of 5328 participants that met the above
criteria were included in the cases group and 5135 others
in the control group. The different stages of CKD and
non-CKD was defined as follows: CKD Stage 1 eGFR ≥ 90
with albumin excretion ≥150 mg and microhematuria
and/or renal parenchymal disease, CKD Stage 2 eGFR
60.0–89.9 with above mentioned criteria, CKD Stage 3
eGFR 30.0–59.9, CKD Stage 4 eGFR 15.0–29.9, CKD
Stage 5 eGFR ˂15, and non-CKD eGFR ≥60 without above
mentioned criteria.
The definition of diabetes and HTN was based on phys-
ician diagnoses using a fasting glucose level of >126 mg/dL
[23] and a systolic/diastolic blood pressure level of >130/
80 mmHg [24], respectively. The study participants were
placed into four groups according to their disease status:
Group I consisted of 3785 participants without both DM
and HTN (1382 cases and 2403 controls), Group II
Fig. 1 Recruitment Process Flow Chart HTN: hypertension; DM: diabetes mellitus; CKD: chronic kidney disease;n: number of participants were
meeting for specific group. We recruited participants without CKD from the HTN/DM outpatient and health centres in each hospital as a control
group. The CKD cases were recruited from both the nephrology and HTN/DM outpatient clinics in each hospital and from health centres
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DM (2026 cases and 1470 controls), Group III consisted
of 1022 participants with DM and without HTN (419
cases and 603 controls) and Group IV consisted of 2160
participants with both DM and HTN (1501 cases and 659
controls).
Risk factor assessment and definition
Demographic characteristics (gender, age, obesity and so-
cioeconomic), history of disease (HB, HC, hyperuricemia,
anaemia and hyperlipidaemia) and lifestyle (smoking sta-
tus, alcohol intake, betel nut chewing, exercise habits and
use of groundwater status) were the possible risk factors
that were investigated for their individual effects and for
the different effects on CKD in the four study groups. A
detailed medical history, anthropometric measurements,
laboratory analyses, and a health appraisal questionnaire
eliciting demographic, socioeconomic and behavioural risk
factors were conducted through face-to-face interviews
with each participant by well-trained investigators at the
initial visit. Written informed consent was obtained from
all study participants.Gender and age were assessed based on self-reporting.
Body mass index (BMI) was calculated as weight/height2
(kg/m2) and participants whose BMI was >27 were classi-
fied as obese. The socioeconomic status was based on
income and individuals were divided into three groups: low
income was defined as less than 20,000 New Taiwan
Dollars (NTD) per month, median income was between
20,000 and 60,000 NTD per month and high income was
more than 60,000 NTD per month (1 US dollar = 30
NTD).
Participants were recorded with a history of disease if
there was an affirmative answer to having ever been diag-
nosed by a doctor with HB, HC, hyperuricemia, anaemia
or hyperlipidaemia. The diagnosis of anaemia used in
Taiwan is defined by the WHO as haemoglobin <12 g/dL
in women and <13 g/dL in men [25].
Smoking status (current, former or never) was ascer-
tained at the time of enrolment. Individuals who had not
smoked more than 100 cigarettes in their lifetime were
classified as never-smokers, based on common conven-
tions in epidemiology research [26]. Others were grouped
together in the smokers group.
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tion in grams per day. We calculated this from questions
about different liquors, frequencies and concentrations.
A previous study reported that moderate alcohol con-
sumption (10–20 g/day) is associated with favourable levels
of several cardiovascular risk factors [27]. Therefore, indi-
viduals who had intakes of >20 g/day that continued for
more than 1 month were classified in the ever-drink group,
and others were classified in the never-drink group.
Betel nut chewing and exercise habits were based on a
self-report questionnaire. If the participants gave a positive
answer to having ever had habits of betel nut chewing or
exercise, they were classified in the ever-group and the
others in the never-group. Individuals who participated in
physical activity fewer than three times/week were classi-
fied in the never-group [26].
Using groundwater was ascertained by the participants
as having and using stable groundwater. Individuals who
used groundwater for a period of more than 1 year were
classified as the ever-used group and others were classi-
fied as the never-used group.
Ethics statement
The study was reviewed and approved by the institutional
ethical committee of Taipei Medical University Hospital
(201204035), Taipei Chang Gung Memorial Hospital
(97-2187B), Tri-Service General Hospital (100-05-197),
Cardinal Tien Hospital (201204035), Shuang Ho Hospital
(201204035), China Medical University Hospital [DMR
101-IRB2-273 (CR-1)], Kaohsiung Medical University
Chung-Ho Memorial Hospital (KMUH-IRB-20120019),
National Cheng Kung University Hospital (ER-101-117),
Changhua Christian Hospital (120405) and Kaohsiung
Chang Gung Memorial Hospital (101-1096B). After a
complete explanation of the study, written informed con-
sent was obtained from all participants. All clinical and
biological samples were collected and DNA was geno-
typed following patient consent.
Statistical analysis
The total cohort, including participants from different
sources (HTN/DM outpatient and health centres) may
have distorted the proportion of cases/controls with
HTN/DM, and this could have resulted in the wrong
risk assessments of HTN/DM and some of the factors
relating to HTN/DM. Therefore, this study did not
investigate the risk of HTN/DM on CKD, because the
exposure rate of HTN/DM may be biased. The HTN/
DM cases were stratified in all analyses in order to in-
vestigate the interactions between HTN/DM and the
other factors, and the stratified analyses could help
reduce the confounding effect.
The significance tests were adjusted by the Bonferroni
method and a p-value of <0.05/14 = 0.0036 was consideredsignificant for avoiding the error of multiple testing. Statis-
tical analyses were conducted with R 3.0.1 software with
the ‘lme4’, ‘meta’ and ‘metafor’ package. The dependent
variable for the analyses was patients with CKD. Categor-
ical and continuous variables were presented as the num-
ber (proportion) and mean ± standard deviation (SD). The
post powers were calculated based on G*Power 3.1.7 [28].
To test the effect of each factor and to control the
hospital-clustering effect (Simpson paradox), all factors
were tested using hierarchical generalised linear models
in the four groups (Groups I–IV). The OR and 95 %
confidence interval (95 % CI) were presented for the ef-
fects of risk factors on CKD. All variables were adjusted
in multivariate analyses regardless of whether they were
significant in the univariate analyses. Meta-analysis was
used to quantify the difference between the coefficients
of a specific variable in the different groups. The I2 test
for estimating the heterogeneity between the four groups
and the Cochrane Q test were used. An I2 > 75 % repre-
sented a high heterogeneity and implied that the inter-
action between that variable and HTN/DM may exist
[29]. The τ2 statistic was estimated by the restricted
maximum-likelihood estimator method, and a random-
effects model based on the Mantel–Haenszel method
was applied. When the heterogeneity of the coefficients
of a specific variable was significant in the multivariate
analyses, we presented the results of the stratified ana-
lyses and attempted to find the cause of heterogeneity
(DM or HTN). Moreover, the results of the pooled ana-
lyses were considered more reliable in study populations.
The change of τ2 statistic that was estimated was used
for assessment for the cause of heterogeneity.
Results
Table 1 shows the proportion of cases and controls with
exposure to all variables. In the post power assessment,
the powers of HC (39.6 %), anaemia (92.1 %) and betel
nut chewing (82.2 %) were <95 %, and the powers of the
other variables were >95 %.
The characteristics of the case and control groups in
Groups I–IV are shown in Table 2, and the hierarchical
generalised linear models were used to test the difference
of proportion between cases and controls by controlling
the hospital-clustering effects in each group (stratified
analyses). Detailed information is shown in the supple-
mentary file (univariate analyses Additional file 1: Table S1
and multivariate analyses Additional file 1: Table S2).
Based on Additional file 1: Table S1 and Additional file 1:
Table S2, Table 3 shows the pooled results of all variables.
Male (p <0.001), hyperuricemia (p <0.001), smoking
(p <0.001), lack of exercise habits (p <0.001) and ground-
water use (p = 0.003) were significant risk factors for
CKD in the univariate analyses, and their heterogeneities
were not significant. In the multivariate analyses, male
Table 1 Overall proportion of cases and controls with exposure
CKD non-CKD Post power
Gender Female 2302 (43.2 %) 2943 (57.3 %) >99.9 %
Male 3026 (56.8 %) 867 (42.7 %)
Age 59.8 ± 15.2 54.0 ± 15.1 >99.9 %
Obesity (151 missing) Normal 4634 (88.7 %) 4650 (91.4 %) >99.9 %
Abnormal 592 (11.3 %) 436 (8.6 %)
Income (61 missing) Low 3056 (57.6 %) 2039 (40.0 %)
Median 1416 (26.7 %) 1791 (35.1 %) >99.9 %
High 832 (15.7 %) 1268 (24.9 %) >99.9 %
HB (1 missing) Normal 5027 (94.4 %) 5064 (93.9 %) 99.4 %
Abnormal 300 (5.6 %) 71 (6.1 %)
HC* (2 missing) Normal 5228 (98.2 %) 5064 (98.6 %) 39.6 %
Abnormal 98 (1.8 %) 71 (1.4 %)
Hyperuricaemia (2 missing) Normal 4036 (75.8 %) 4852 (94.5 %) 98.7 %
Abnormal 1291 (24.2 %) 282 (5.5 %)
Anaemia* (2 missing) Normal 4463 (83.8 %) 4938 (96.2 %) 92.1 %
Abnormal 863(16.2 %) 197 (3.8 %)
Hyperlipidaemia (1 missing) Normal 3832 (71.9 %) 4196 (81.7 %) >99.9 %
Abnormal 1495 (28.1 %) 939 (18.3 %)
Smoking status (338 missing) Never 3909 (76.0 %) 4126 (82.9 %) >99.9 %
Ever 1237 (24.0 %) 853 (17.1 %)
Alcohol intake (382 missing) Never 4361 (85.0 %) 4340 (87.6 %) >99.9 %
Ever 767 (15.0 %) 613 (12.4 %)
Betel nut chewing* (456 missing) Never 4876 (95.7 %) 4758 (96.9 %) 82.2 %
Ever 222 (4.3 %) 151 (3.1 %)
Exercise habits (173 missing) Never 1862 (35.8 %) 1511 (29.7 %) >99.9 %
Ever 3338 (64.2 %) 3579 (70.3 %)
Groundwater using (17 missing) Never 5029 (94.5 %) 4890 (95.4 %) 96.6 %
Ever 293 (5.5 %) 234 (4.6 %)
CKD: patients with CKD; non-CKD: patients without CKD; HB: hepatitis B; HC: hepatitis C
§: Post power (1-β) estimate based on G*power [28]
Boldface & *: the powers of each variable were less than 95 %, and they were defined as lacking in power
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habits (p <0.001) were significant and their heterogeneities
were not significant. However, smoking (p = 0.026) and
groundwater use (p = 0.022) were not significant after ad-
justment by the Bonferroni method. The pooled ORs of
gender, hyperuricemia and exercise habits were 1.61 (95 %
CI = 1.45–1.78, p <0.001), 3.63 (95 % CI = 3.11–4.24,
p <0.001) and 0.71 (95 % CI = 0.64–0.79, p <0.001). Age
and income may relate to CKD, but they had high hetero-
geneity between the four groups (I2 of age 85.7 %, I2 of in-
come 80.8 % and 82.3 %). This implies that the pooled
ORs of these variables may be unreliable. However, the
heterogeneities were significantly reduced after the ad-
justed demographic characteristics, the history of disease
and lifestyle. The pooled ORs per 10 years of age was 1.44
(95 % CI = 1.13–1.83, p = 0.003) and of income for Medianvs. Low was 0.58 (95 % CI = 0.47–0.73 p <0.001) and for
High vs. Low was 0.55 (95 % CI = 0.43–0.70, p <0.001),
which were all statistically significant.
The heterogeneities of obesity, HB, HC, alcohol intake
and betel nut chewing were not significant in the univar-
iate/multivariate analyses, and their pooled ORs were
not significant. Based on the power of this study, obesity,
HB and alcohol intake may not be associated with CKD
(unless their true ORs were very small), but the power
of the significance test in HC and betel nut chewing may
be insufficient.
The results of anaemia and hyperlipidaemia were in-
teresting. We found that there was high and significant
heterogeneity among the four groups. The I2 of anaemia
was 88.5 % for univariate and 82.2 % for multivariate
analyses, and the I2 of hyperlipidaemia was 80.5 % for
Table 2 Characteristics of subjects by stratification for HTN and DM
Group I Group II Group III Group IV
CKD non-CKD CKD non-CKD CKD non-CKD CKD non-CKD
Gender Female 670 (48.5 %) 1536 (63.9 %) 819 (40.4 %) 752 (51.2 %) 172 (41.1 %) 304 (50.4 %) 641 (42.7 %) 351 (53.3 %)
Male 712 (51.5 %) 867 (36.1 %) 1207 (59.6 %) 718 (48.8 %) 247 (58.9 %) 299 (49.6 %) 860 (57.3 %) 308 (46.7 %)
Age 53.0 ± 17.1 47.3 ± 15.2 61.3 ± 15.1 60.5 ± 13.0 61.7 ± 12.1 57.6 ± 12.1 63.5 ± 11.8 60.8 ± 10.8
Obesity (151 missing) Normal 1278 (93.6 %) 2234 (94.0 %) 1787 (89.8 %) 1311 (90.1 %) 356 (86.2 %) 538 (89.8 %) 1213 (83.3 %) 567 (86.6 %)
Abnormal 87 (6.4 %) 143 (6.0 %) 204 (10.2 %) 144 (9.9 %) 57 (13.8 %) 61 (10.2 %) 244 (16.7 %) 88 (13.4 %)
Income (61 missing) Low 648 (47.3 %) 677 (28.3 %) 1153 (57.0 %) 736 (50.3 %) 265 (63.4 %) 260 (44.0 %) 990 (66.4 %) 366 (56.2 %)
Median 434 (31.7 %) 971 (40.6 %) 554 (27.4 %) 418 (28.6 %) 97 (23.2 %) 213 (36.0 %) 331 (22.2 %) 189 (29.0 %)
High 289 (21.1 %) 746 (31.2 %) 316 (15.6 %) 308 (21.1 %) 56 (13.4 %) 118 (20.0 %) 171 (11.5 %) 96 (14.7 %)
HB (1 missing) Normal 1273 (92.1 %) 2222 (92.5 %) 1905 (94.0 %) 1399 (95.2 %) 402 (95.9 %) 574 (95.2 %) 1447 (96.5 %) 629 (95.4 %)
Abnormal 109 (7.9 %) 181 (7.5 %) 121 (6.0 %) 71 (4.8 %) 17 (4.1 %) 29 (4.8 %) 53 (3.5 %) 30 (4.6 %)
HC (2 missing) Normal 1358 (98.3 %) 2377 (98.9 %) 1984 (97.9 %) 1446 (98.4 %) 412 (98.3 %) 593 (98.3 %) 1474 (98.3 %) 648 (98.3 %)
Abnormal 23 (1.7 %) 26 (1.1 %) 42 (2.1 %) 24 (1.6 %) 7 (1.7 %) 10 (1.7 %) 26 (1.7 %) 11 (1.7 %)
Hyperuricemia (2 missing) Normal 1185 (85.7 %) 2335 (97.2 %) 1398 (69.0 %) 1336 (90.9 %) 367 (87.6 %) 572 (94.9 %) 1086 (72.4 %) 609 (92.4 %)
Abnormal 197 (14.3 %) 68 (2.8 %) 628 (31.0 %) 133 (9.1 %) 52 (12.4 %) 31 (5.1 %) 414 (27.6 %) 50 (7.6 %)
Anaemia (2 missing) Normal 1217 (88.1 %) 2285 (95.1 %) 1674 (82.6 %) 1431 (97.3 %) 383 (91.4 %) 588 (97.5 %) 1189 (79.3 %) 634 (96.2 %)
Abnormal 165 (11.9 %) 118 (4.9 %) 352 (17.4 %) 39 (2.7 %) 36 (8.6 %) 15 (2.5 %) 310 (20.7 %) 25 (3.8 %)
Hyperlipidaemia (1 missing) Normal 1144 (82.8 %) 2184 (90.9 %) 1478 (73.0 %) 1123 (76.4 %) 308 (73.5 %) 460 (76.3 %) 902 (60.1 %) 429 (65.1 %)
Abnormal 238 (17.2 %) 219 (9.1 %) 548 (27.0 %) 347 (23.6 %) 111 (26.5 %) 143 (23.7 %) 598 (39.9 %) 230 (34.9 %)
Smoking status (338 missing) Never 1088 (80.5 %) 2041 (87.6 %) 1496 (76.6 %) 1148 (80.8 %) 288 (71.1 %) 438 (74.9 %) 1037 (72.2 %) 499 (77.7 %)
Ever 263 (19.5 %) 290 (12.4 %) 457 (23.4 %) 273 (19.2 %) 117 (28.9 %) 147 (25.1 %) 400 (27.8 %) 143 (22.3 %)
Alcohol intake (382 missing) Never 1203 (89.0 %) 2109 (91.1 %) 1658 (85.2 %) 1209 (85.4 %) 338 (83.9 %) 480 (82.2 %) 1162 (81.4 %) 542 (85.0 %)
Ever 148 (11.0 %) 207 (8.9 %) 289 (14.8 %) 206 (14.6 %) 65 (16.1 %) 104 (17.8 %) 265 (18.6 %) 96 (15.0 %)
Betel nut chewing (456 missing) Never 1296 (96.7 %) 2257 (98.5 %) 1870 (96.6 %) 1360 (97.0 %) 374 (93.0 %) 539 (92.8 %) 1336 (94.1 %) 602 (95.0 %)
Ever 44 (3.3 %) 35 (1.5 %) 66 (3.4 %) 42 (3.0 %) 28 (7.0 %) 42 (7.2 %) 84 (5.9 %) 32 (5.0 %)
Exercise habits (173 missing) Never 474 (34.8 %) 755 (31.7 %) 691 (35.0 %) 389 (26.7 %) 138 (33.5 %) 173 (28.9 %) 559 (38.6 %) 194 (29.6 %)
Ever 887 (65.2 %) 1624 (68.3 %) 1286 (65.0 %) 1068 (73.3 %) 274 (66.5 %) 426 (71.1 %) 891 (61.4 %) 461 (70.4 %)
Groundwater using (17 missing) Never 1312 (95.2 %) 2334 (97.3 %) 1904 (94.0 %) 1349 (92.0 %) 394 (94.0 %) 574 (95.5 %) 1419 (94.7 %) 633 (96.2 %)
Ever 66 (4.8 %) 65 (2.7 %) 122 (6.0 %) 117 (8.0 %) 25 (6.0 %) 27 (4.5 %) 80 (5.3 %) 25 (3.8 %)
Group I: participants without DM and HTN; Group II: participants with HTN without DM; Group III: participants with DM without HTN; Group IV: participants with and HTN












Table 3 Pooled data showing effect of each risk factor on CKD and heterogeneity between the four groups§
Univariable analyses Multivariable analyses
OR (95 % CI) I2 Q test OR (95 % CI) I2 Q test
Gender (Male versus Female) 1.65 (1.49 to 1.82)* 25.5 % 0.296 1.61 (1.45 to 1.78)* 0.0 % 0.934
Age (per 10 years) 1.19 (1.09 to 1.29)*£ 85.7 %* <0.001* 1.44 (1.13 to 1.83)* 24.1 % 0.323
Obesity (Abnormal versus Normal) 1.14 (0.93 to 1.40) 43.9 % 0.163 1.07 (0.86 to 1.33) 39.0 % 0.204
Income (Median versus Low) 0.57 (0.45 to 0.72)*£ 80.8 %* <0.001* 0.58 (0.47 to 0.73)* 71.9 % 0.011
(High versus Low) 0.50 (0.38 to 0.67)*£ 82.3 %* <0.001* 0.55 (0.43 to 0.70)* 65.0 % 0.022
HB (Abnormal versus Normal) 1.08 (0.88 to 1.33) 21.6 % 0.263 1.25 (1.03 to 1.52) 0.0 % 0.523
HC (Abnormal versus Normal) 1.29 (0.93 to 1.79) 0.0 % 0.707 1.22 (0.85 to 1.74) 0.0 % 0.778
Hyperuricaemia (Abnormal versus Normal) 4.56 (3.96 to 5.26)* 0.0 % 0.213 3.63 (3.11 to 4.24)* 0.0 % 0.806
Anaemia (Abnormal versus Normal) 4.89 (2.76 to 8.66)*£ 88.5 %* <0.001* 4.64 (2.81 to 7.65)*£ 82.2 %* <0.001*
Hyperlipidaemia (Abnormal versus Normal) 1.48 (1.17 to 1.88)*£ 80.5 %* 0.001 1.28 (0.97 to 1.67)£ 81.3 %* 0.001*
Smoking status (Abnormal versus Normal) 1.45 (1.28 to 1.64)* 26.6 % 0.305 1.17 (1.02 to 1.34) 0.0 % 0.559
Alcohol intake (Abnormal versus Normal) 1.15 (1.00 to 1.33) 22.3 % 0.248 0.83 (0.71 to 0.97) 0.0 % 0.701
Betel nut chewing (Abnormal versus Normal) 1.35 (1.03 to 1.77) 29.0 % 0.233 1.10 (0.85 to 1.44) 0.0 % 0.836
Exercise habits (Abnormal versus Normal) 0.74 (0.65 to 0.85)* 50.9 % 0.106 0.71 (0.64 to 0.79)* 0.0 % 0.859
Groundwater using (Abnormal versus Normal) 1.44 (1.13 to 1.83) 24.1 % 0.323 1.29 (1.04 to 1.61) 0.0 % 0.534
§: The four groups were Group I (participants without DM and HTN), Group II (participants with HTN without DM), Group III (participants with DM without HTN)
and Group IV (participants with DM and HTN)
HB: hepatitis B; HC: hepatitis C
OR: pooled odds ratio for variation groups compared with reference groups on CKD; 95 % CI: 95 % confidence interval of OR
I2: heterogeneity between four groups in each variable; Q test: the significant test of I2 using Cochrane Q test
Boldface & *: significance after Bonferroni adjustment: p value <0.05/14 = 0.0036
£: The pooled results were unreliable because the difference between coefficients in four group were significant. Please refer to the results of stratified analyses in
Supplementary File (univariable analyses: Additional file 1: Table S1; multivariable analyses: Additional file 1: Table S2)
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sults imply that the pooled ORs may be unreliable. Fig. 2
shows further analyses that indicate the causes of het-
erogeneity for anaemia (93.7 %) and hyperlipidaemia
(100 %) may be due to HTN. After the recombined ana-
lyses, the ORs of anaemia and hyperlipidaemia were 6.75
(95 % CI = 4.76–9.68, p <0.001) and 1.03 (95 % CI =
0.89–1.19, p = 0.695), respectively, in patients with HTN,
and the ORs of anaemia and hyperlipidaemia were 2.83
(95 % CI = 2.16–3.67, p <0.001) and 1.67 (95 % CI =
1.38–2.01, p <0.001), respectively, in people without
HTN. These results represent an additive interaction ef-
fect of anaemia and HTN on CKD, and an antagonistic
interaction effect of hyperlipidaemia and HTN on CKD.
Discussion
The results of this study found that male, ageing, low in-
come, hyperuricemia and lack of exercise habits were risk
factors for CKD. The effects of anaemia and hyperlipid-
aemia on CKD in patients with or without HTN were
different. We also found that HB, HC, smoking, alcohol
intake, betel nut chewing and groundwater use may not
be associated with CKD. Among males, ageing and lack of
exercise habits were the traditional risk factors for CKD
[7, 6, 17, 16]. In our study, we also observed a significant
association between these risk factors and CKD, and wedid not find high heterogeneity among the four groups.
The discussion that follows divides the associations be-
tween other variables and CKD into three parts: socioeco-
nomic status-related factors, possible reasons for the high
prevalence of ESRD in Taiwan and the interactive effects
between anaemia/hyperlipidaemia and HTN on CKD.
Low income was an important predictive factor for
CKD, and it was characteristic of people with a low socio-
economic status. Socioeconomic status may be related to
many risk factors, such as second-hand tobacco smoke
[30] and unhealthy diets [31]. In this study, we investi-
gated some socioeconomic status-related factors (smoking
status [32], alcohol intake [33], betel nut chewing [34] and
groundwater use [18]), and we found that the association
between smoking status/groundwater use and CKD may
be related to income level. Their effects were significant
before the adjustment of income but not after this
adjustment.
The ORs of alcohol intake and betel nut chewing in the
univariate and multivariate analyses also presented a simi-
lar phenomenon. Previous studies that had investigated
the above factors did not adjust for socioeconomic status.
Thus, they may have overrated their risk on CKD [14, 15,
18]. Based on the power of this study, further research is
needed concerning the association between betel nut
chewing and CKD. With smoking status, alcohol intake
Fig. 2 Stratified analyses for variables with significant heterogeneity
between the four groups using multivariable analyses. (a) shows
coefficients of anaemia and (b) shows coefficients of
hyperlipidaemia using multivariate analyses and their heterogeneity
caused by HTN in the different groups. Amount of heterogeneity
accounted for by HTN was 93.71 %/100 %. The odds ratios and 95 %
CI of anaemia in patients with or without HTN were 6.75 (4.76–9.68)
and 2.83 (2.16–3.67), respectively. The odds ratios (95 % CI) of
hyperlipidaemia in patients with or without HTN were 1.03
(0.89–1.19) and 1.67 (1.38–2.01), respectively HTN: hypertension;
DM: diabetes mellitus; log (OR): natural logarithm of the odds ratio;
95 % CI: 95 % confidence interval of log (OR)
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CKD. Intervention for these small impact factors may not
be effective, and therefore, we determined that smoking
status, alcohol intake and betel nut chewing were not the
best targets for CKD prevention.
The prevalence of HB [35] and HC [36] in Taiwan is
higher than in most other countries, and Taiwan has the
highest prevalence and third highest incidence of ESRD
in the world [2]. Previous studies have reported the asso-
ciation between HC and CKD [11], so we suspected that
the high prevalence of hepatitis might be the main rea-
son for the high prevalence of ESRD. However, our study
showed the nonsignificance of these factors. Therefore,
we determined that HB and HC were not the main rea-
son for the high prevalence and incidence of ESRD in
Taiwan, but the power of HC may be insufficient and
needs further research.
People with hyperuricemia have a higher risk of ESRD
than those without it, and the association was found to
be very high in this study. Despite the lack of detailedstatistics worldwide, we believe that the prevalence of
hyperuricemia in Taiwan may be higher than in many
other countries [37, 38], and this may also play a key
role in ESRD in Taiwan. However, our study might have
overrated the risk of hyperuricemia in CKD. Previous
studies presented a significant association between
hyperuricemia and CKD, but the relative risks in these
studies were <2 [7, 21]. Therefore, we determined that
hyperuricemia might be associated with CKD, but the
effect of intervention for hyperuricemia-related factors
on CKD might not be very effective.
Anaemia is a likely complication in patients with CKD,
but this is not a cause [39]. Therefore, it is not a good
target for the prevention of CKD. However, this study
was not only concerned with prevention strategies but
also with screening strategies for CKD. Previous studies
have demonstrated that awareness of CKD in patients is
very low [40, 41]. Therefore, physicians might have to
help them with monitoring the CKD. This study showed
a strong association between anaemia and CKD in pa-
tients with HTN but not in the general population. This
result helps to better pinpoint CKD high risk groups.
Patients with both anaemia and HTN are a newly
discovered high risk group for CKD, and physicians in
outpatient clinics need to recognise that patients with an-
aemia accompanied with HTN might be latent CKD cases.
The risk effect of hyperlipidaemia on CKD was only
found to be in the general population, but not in patients
with HTN as reported in an earlier study [7]. Male sub-
jects had a higher prevalence of HTN than females, and
the hazard ratio of hyperlipidaemia on CKD in males was
lower than in females [7]. Obesity was a hyperlipidaemia-
related factor, and the risk effects of obesity presented
similar results (Additional file 1: Table S1 and Additional
file 1: Table S2). Although the results were not significant,
we still found that the ORs in patients with HTN were
lower than those in people without HTN. In addition, the
heterogeneity of obesity was 39.0 % in the multivariate
analysis, which implies that HTN might be a moderate
factor in the association between obesity-related factors
and CKD. It has been reported that renal lipid accumula-
tion is nephrotoxic and could play a role in CKD [42], but
we are unable to explain why the association between
hyperlipidaemia and CKD in patients with HTN has a
negative impact. Further research is required to under-
stand the basic mechanism.
This study has two limitations. First, a cross-sectional
study is not the way to distinguish whether correlations
were causative or not, and time relationships were not
confirmed in this study. Most of our discussion has
focused on this issue, and we surmised that associations
between some factors and CKD might not be causative.
Although these may not help prevent CKD, they are
useful for planning a screening strategy. Low awareness
Su et al. BMC Nephrology  (2015) 16:83 Page 9 of 10of CKD is an important issue, and a good outpatient
screening strategy is urgently needed. Second, the risk fac-
tors assessment was based on a structured questionnaire
rather than on the laboratory data. This may have caused
some misclassification. However, Taiwan has good medical
accessibility and most people can easily obtain medical
resources and understand their disease status. In addition,
our interviewers were highly trained, and we regularly
held meetings for feedback from the interviewers. This
ensured the quality of our research and reduced the possi-
bility of misclassification.Conclusions
Gender, age, income, hyperuricemia, anaemia, hyperlipid-
aemia and exercise habits were good targets for planning
a screening/prevention strategy for CKD in healthy popu-
lations and in patients with DM. In addition, the import-
ant evidence from this study confirmed that HB, smoking
status, alcohol intake and groundwater use were not good
targets for CKD prevention. They were not associated
with CKD or only had a low impact on the condition. We
believe that intervention for related factors might not be
an efficient method based on the strong statistical power
in this study. The associations between HC/betel nut
chewing and CKD require further research because they
were underpowered in this study. Finally, this study sug-
gested that a specific CKD screening/prevention strategy
for patients with DM might not be efficient without
laboratory data analyses, and the strategy for the general
population could be used in patients with DM. Further-
more, we determined that a screening/prevention strategy
for CKD in patients with HTN might differ from that of a
healthy population. Hyperlipidaemia-related factors might
not be a good target for patients with HTN, and physi-
cians need to recognise that patients with HTN in an-
aemia outpatient clinics might be potential CKD patients.
In addition, there is a need for better care in patients with
anaemia and HTN and timely intervention is required
when there are signs of deterioration.Additional file
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